Fatigue, quality of life and metabolic changes in men treated with first-line enzalutamide versus abiraterone plus prednisolone for metastatic castration-resistant prostate cancer (HEAT):A randomised trial protocol

Authors
Publication date
1 January 2019
Publisher
'BMJ'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Copenhagen University Research Information System

      redirect
      oaioai:pure.atira.dk:publications...
      Last time updated on 12/04/2020